A high drug failure rate is more than just a pattern recognition problem. Here's how we can address some of the root causes.

The cell atlas, called Hypomap, developed by researchers at the Max Planck Institute for Metabolism Research in Cologne and ...

Scientists develop groundbreaking dual-action drug RI-AG03 that targets toxic tau proteins in Alzheimer's disease, showing ...

Understanding the behavior of tiny droplets in our cells could aid the search for new treatments. A team of Leiden ...

Cell line development plays a pivotal role in the manufacturing of therapeutic proteins, vaccines and other biologics.

Discover seven companies operating in metabolomics, the field that could significantly boost precision medicine.

Researchers at the University of Toronto see a future where a single injection under the eyelid could replace months of daily ...

Neuropsychiatric disorders are becoming increasingly prevalent. Given their complex and multifactorial pathogenesis, there is ...

With positive mid-stage results in marginal zone lymphoma, Bristol Myers Squibb could soon add a new indication for the CAR T ...

“Tuberculosis cells are clumpy and seem to always stick close to each ... s TB research capabilities and helped identify ...

Because cancer cells have a lot of P-cadherin sticking out of their surface, the protein has been targeted for drug development. Monoclonal antibodies against P-cadherin can carry a drug payload to ...